loading
前日終値:
$7.88
開ける:
$7.83
24時間の取引高:
1.09M
Relative Volume:
0.74
時価総額:
$930.88M
収益:
-
当期純損益:
$-258.08M
株価収益率:
-2.76
EPS:
-2.75
ネットキャッシュフロー:
$-202.32M
1週間 パフォーマンス:
-9.96%
1か月 パフォーマンス:
-19.26%
6か月 パフォーマンス:
-58.88%
1年 パフォーマンス:
-71.83%
1日の値動き範囲:
Value
$7.48
$7.94
1週間の範囲:
Value
$7.48
$8.80
52週間の値動き範囲:
Value
$7.48
$26.99

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
名前
Rocket Pharmaceuticals Inc
Name
セクター
Healthcare (1166)
Name
電話
646-440-9100
Name
住所
350 FIFTH AVENUE, NEW YORK, NY
Name
職員
0
Name
Twitter
@rocketpharma
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
RCKT's Discussions on Twitter

RCKT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
7.59 930.88M 0 -258.08M -202.32M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-12 開始されました BMO Capital Markets Outperform
2024-12-30 開始されました Wedbush Outperform
2024-12-18 開始されました Jefferies Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-04-02 開始されました Goldman Neutral
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-02-01 開始されました Morgan Stanley Overweight
2022-11-08 開始されました Canaccord Genuity Buy
2022-11-01 開始されました BTIG Research Buy
2022-07-08 開始されました Raymond James Outperform
2021-10-20 再開されました Cowen Outperform
2021-03-02 開始されました Stifel Buy
2021-02-18 開始されました Needham Buy
2020-12-16 開始されました UBS Buy
2020-12-08 ダウングレード Oppenheimer Outperform → Perform
2020-07-02 開始されました JP Morgan Overweight
2020-06-25 再開されました BofA/Merrill Buy
2020-06-01 再開されました Oppenheimer Outperform
2019-11-06 開始されました Chardan Capital Markets Buy
2019-09-26 開始されました Piper Jaffray Overweight
2019-04-23 開始されました Robert W. Baird Outperform
2019-03-15 開始されました BofA/Merrill Buy
2019-02-05 開始されました Oppenheimer Outperform
2018-09-13 開始されました Ladenburg Thalmann Buy
2018-07-10 開始されました William Blair Outperform
すべてを表示

Rocket Pharmaceuticals Inc (RCKT) 最新ニュース

pulisher
04:15 AM

Swiss National Bank Has $1.93 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

04:15 AM
pulisher
Mar 26, 2025

Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - Yahoo Finance

Mar 26, 2025
pulisher
Mar 24, 2025

Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Cantor Fitzgerald maintains Overweight on Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

Charles Schwab Investment Management Inc. Has $8.25 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 24, 2025
pulisher
Mar 22, 2025

(RCKT) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 22, 2025
pulisher
Mar 22, 2025

PNC Financial Services Group Inc. Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Bank of New York Mellon Corp Buys 9,949 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Fanconi Anemia Pipeline 2025: FDA Approvals and Clinical Trials - openPR

Mar 20, 2025
pulisher
Mar 19, 2025

What technical indicators reveal about RCKT stock - US Post News

Mar 19, 2025
pulisher
Mar 18, 2025

Steward Partners Investment Advisory LLC Has $84,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 18, 2025
pulisher
Mar 16, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Arizona State Retirement System - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

(RCKT) Investment Analysis and Advice - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital Initiates Coverage on Rocket Pharmaceuticals With Outperform Rating, $50 Price Target - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

BMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform Recommendation - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Rocket Pharmaceuticals: A Buy Rating for Its Pioneering Gene Therapy Approach and Promising Pipeline - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

BMO Capital sets $50 target for Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 08, 2025

Private Advisor Group LLC Acquires Shares of 13,199 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by New York State Common Retirement Fund - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Rhumbline Advisers Has $1.25 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Research Analysts Set Expectations for RCKT FY2025 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - Insider Monkey

Mar 05, 2025
pulisher
Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025
pulisher
Mar 04, 2025

Handelsbanken Fonder AB Has $290,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $15.00 by Analysts at The Goldman Sachs Group - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $52.00 at Scotiabank - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Lowered to $36.00 at Canaccord Genuity Group - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low on Analyst Downgrade - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Rocket Pharmaceuticals Inc (NASDAQ: RCKT)’s Stock Adds 0.53%, Making It A Good Investment - Stocks Register

Mar 03, 2025
pulisher
Mar 03, 2025

Scotiabank raises Rocket Pharmaceuticals target to $52 - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

What is William Blair’s Estimate for RCKT Q1 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

What is Leerink Partnrs’ Estimate for RCKT Q2 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Chardan Capital Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $54.00 - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

Needham & Company LLC Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $42.00 - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs - MSN

Mar 02, 2025
pulisher
Mar 02, 2025

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? - Yahoo Finance Australia

Mar 02, 2025
pulisher
Mar 01, 2025

Decoding Rocket Pharmaceuticals Inc (RCKT): A Strategic SWOT Ins - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Advances Gene Therapy Pipeline - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month LowHere's What Happened - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Rings the Opening Bell - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald cuts Rocket Pharmaceuticals target to $50 By Investing.com - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals: Q4 Earnings Snapshot - The Washington Post

Feb 28, 2025

Rocket Pharmaceuticals Inc (RCKT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rocket Pharmaceuticals Inc (RCKT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Schwartz Jonathan David
See Remarks
May 17 '24
Sale
23.35
2,754
64,306
169,659
Schwartz Jonathan David
See Remarks
Aug 16 '24
Sale
18.50
2,710
50,135
166,949
Schwartz Jonathan David
See Remarks
Nov 21 '24
Sale
13.05
3,097
40,416
163,852
Patel Kinnari
See Remarks
Feb 21 '25
Sale
10.58
6,078
64,305
444,103
Wilson Martin
General Counsel
Feb 21 '25
Sale
10.58
3,222
34,089
150,696
Militello John
See Remarks
Feb 21 '25
Sale
10.58
2,737
28,957
65,757
Shah Gaurav
CEO
Feb 21 '25
Sale
10.58
16,303
172,486
772,680
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):